The subjects’ blood pressure, weight, height, waist and hip circumferences, and skinfold thicknesses (triceps and subscapular) were measured according to standardized techniques. Subjects were categorized as obese if their body-mass index was 30 or more.11 Two definitions of overweight were used, the standard World Health Organization11 cutoff value of a body-mass index of 25 and that recommended for Asians12 of 23.
A standard glucose-tolerance test with an oral 75-g anhydrous glucose load was administered.13 Plasma glucose concentrations in samples obtained after an overnight fast and 30 and 120 minutes after the ingestion of glucose (fasting, 30-minute, and 120-minute values) were analyzed by means of a glucose oxidase method (GOD-PAP, Randox) with a Beckman autoanalyzer. Aliquots of plasma were stored at −70°C for up to eight months, and insulin concentrations were measured by radioimmunoassay (Coat-a-Count insulin kit, Diagnostic Products). The intraassay and interassay coefficients of variation were less than 5 percent and less than 7.5 percent, respectively. Insulin resistance was calculated according to the homeostasis-model assessment.14 (link)The 30-minute increment in insulin — calculated as the (30-minute insulin concentration–the fasting insulin concentration)÷the 30-minute glucose concentration — was used as a measure of first-phase insulin secretion.15 (link) Impaired glucose tolerance was defined as a fasting plasma glucose concentration of less than 126 mg per deciliter (7.0 mmol per liter) and a 120-minute value of at least 141 mg per deciliter (7.8 mmol per liter); diabetes was defined as a fasting glucose concentration of at least 126 mg per deciliter or a 120-minute concentration of at least 200 mg per deciliter (11.1 mmol per liter).13 The All India Institute of Medical Sciences approved the study. Informed consent was obtained from each subject.